Detalles de la búsqueda
1.
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA-Mutated Metastatic Castrate-Resistant Prostate Cancer.
Oncologist
; 26(2): 139-146, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33145877
2.
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development.
PLoS Comput Biol
; 14(12): e1006614, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30532240
3.
Regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary.
J Inherit Metab Dis
; 44(5): 1085-1087, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34337775
4.
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements.
Clin Cancer Res
; 29(20): 4027-4031, 2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37289037
5.
Premarket assessment of molecular alterations in drug targets: a case study of 2020 drug approvals.
Pharmacogenomics
; 23(7): 397-404, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35440173
6.
Clinical Pharmacology Studies Supporting Oligonucleotide Therapy Development: An Assessment of Therapies Approved and in Development Between 2012 and 2018.
Clin Transl Sci
; 14(2): 468-475, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33278337
7.
An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials.
Clin Pharmacol Ther
; 106(4): 841-846, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31002380
Resultados
1 -
7
de 7
1
Próxima >
>>